Cargando…
EYE-503: A Novel Retinoic Acid Drug for Treating Retinal Neurodegeneration
Retinal neurodegeneration is a major cause of vision loss. Retinoic acid signaling is critical for the maintenance of retinal function, and its dysfunction can cause retinal neurodegeneration. However, the therapeutic effects of retinoic acid drugs on retinal neurodegeneration remain unclear. In thi...
Autores principales: | Liu, Sha, Ji, Yuke, Li, Huan, Ren, Ling, Zhu, Junya, Yang, Tianjing, Li, Xiumiao, Yao, Jin, Cao, Xin, Yan, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386480/ https://www.ncbi.nlm.nih.gov/pubmed/37513944 http://dx.doi.org/10.3390/ph16071033 |
Ejemplares similares
-
A novel retinoic acid drug, EYE-502, inhibits choroidal neovascularization by targeting endothelial cells and pericytes
por: Shen, Yaming, et al.
Publicado: (2023) -
LncRNA ZNF503-AS1 promotes RPE differentiation by downregulating ZNF503 expression
por: Chen, Xue, et al.
Publicado: (2017) -
Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005) -
LncRNA MIR503HG Promotes High-Glucose-Induced Proximal Tubular Cell Apoptosis by Targeting miR-503-5p/Bcl-2 Pathway
por: Cao, Xu, et al.
Publicado: (2020) -
Targeting long noncoding RNA-AQP4-AS1 for the treatment of retinal neurovascular dysfunction in diabetes mellitus
por: Li, Xiumiao, et al.
Publicado: (2022)